Chemed CHE Amortization expense related to capitalized debt issuance costs
Amortization expense related to capitalized debt issuance costs at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's amortization expense related to capitalized debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Chemed's amortization expense related to capitalized debt issuance costs?
- Chemed (CHE) reported amortization expense related to capitalized debt issuance costs of $80K in Q1 2026.
- How has Chemed's amortization expense related to capitalized debt issuance costs changed year-over-year?
- Chemed's amortization expense related to capitalized debt issuance costs decreased by 0.0% year-over-year, from $80K to $80K.
- What is the long-term trend for Chemed's amortization expense related to capitalized debt issuance costs?
- Over 4 years (2021 to 2025), Chemed's amortization expense related to capitalized debt issuance costs has grown at a 1.2% compound annual growth rate (CAGR), from $306K to $321K.